Dimensional Fund Advisors’s Exagen XGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$291K Hold
62,571
﹤0.01% 3035
2026
Q1
$188K Buy
62,571
+36,213
+137% +$140K ﹤0.01% 3073
2025
Q4
$160K Sell
26,358
-1,029
-4% -$9.37K ﹤0.01% 3108
2025
Q3
$301K Sell
27,387
-2,835
-9% -$25.1K ﹤0.01% 3068
2025
Q2
$211K Hold
30,222
﹤0.01% 3107
2025
Q1
$109K Hold
30,222
﹤0.01% 3198
2024
Q4
$124K Buy
30,222
+435
+1% +$1.57K ﹤0.01% 3218
2024
Q3
$92.1K Buy
29,787
+8,748
+42% +$22.7K ﹤0.01% 3249
2024
Q2
$38.3K Sell
21,039
-5,398
-20% -$9.14K ﹤0.01% 3330
2024
Q1
$42K Sell
26,437
-9,593
-27% -$18.6K ﹤0.01% 3339
2023
Q4
$71.7K Sell
36,030
-18,369
-34% -$31.8K ﹤0.01% 3313
2023
Q3
$133K Sell
54,399
-13,462
-20% -$34.1K ﹤0.01% 3280
2023
Q2
$197K Buy
67,861
+2,604
+4% +$7.41K ﹤0.01% 3239
2023
Q1
$159K Buy
+65,257
New +$169K ﹤0.01% 3244
2022
Q3
$191K Buy
70,511
+1,698
+2% +$9.47K ﹤0.01% 3247
2022
Q2
$395K Sell
68,813
-3,238
-4% -$18.9K ﹤0.01% 3116
2022
Q1
$579K Buy
72,051
+24,038
+50% +$207K ﹤0.01% 3112
2021
Q4
$558K Buy
48,013
+14,818
+45% +$174K ﹤0.01% 3141
2021
Q3
$451K Buy
33,195
+19,035
+134% +$253K ﹤0.01% 3208
2021
Q2
$212K Buy
+14,160
New +$217K ﹤0.01% 3328

Other funds holding XGN

Dimensional Fund Advisors's XGN Position: Q2 2026 in Review

Dimensional Fund Advisors held its Exagen (XGN) position steady in Q2 2026 at 62,571 shares worth $291K. The position accounts for ﹤0.01% of the portfolio, ranked #3035.

Dimensional Fund Advisors first reported a position in XGN in Q2 2021 and has held it in 20 quarters since. The position peaked at $579K in Q1 2022. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Dimensional Fund Advisors held 62,571 shares of Exagen worth $291K as of Q2 2026.
  • Dimensional Fund Advisors left its Exagen share count unchanged in Q2 2026.
  • Exagen made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #3035 holding.
  • Dimensional Fund Advisors first reported a position in Exagen in Q2 2021 and has held it in 20 quarters since.
  • Dimensional Fund Advisors's Exagen position peaked at $579K in Q1 2022.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.